Does Ejection Fraction Improve After Valve Replacement?

Ejection fraction does improve after valve replacement in most patients, though the degree and speed of recovery depend heavily on which valve is involved, what disease damaged it, and how much the heart muscle has already changed before surgery. For aortic stenosis, the evidence is especially encouraging: large registries show that roughly 60% of patients with severely reduced pumping function recover at least 10 percentage points of ejection fraction after the procedure. The picture is more complicated for mitral valve disease, where ejection fraction often drops in the short term even when the surgery goes well, and for tricuspid valve disease, where right-sided heart function follows its own trajectory.

Aortic Stenosis and the Pressure-Relief Effect

Aortic stenosis is the condition where the most consistent improvements in ejection fraction have been documented. When the aortic valve narrows, the left ventricle has to squeeze against increasing resistance with every beat. The muscle thickens in response, and over time this pressure overload weakens it. Replacing the valve removes that obstruction, and the heart often responds by pumping more efficiently almost immediately.

A European registry of nearly 11,000 patients who underwent transcatheter aortic valve implantation found that among the 914 with severe left ventricular dysfunction beforehand, about 60% gained at least 10 percentage points of ejection fraction, and roughly a quarter normalized entirely to 50% or above.¹ A study comparing transcatheter and surgical aortic valve replacement in patients with low ejection fraction found that both approaches produced similar gains, with average ejection fraction rising from about 28% at baseline to the mid-to-upper 30s afterward.² Another study looking at patients with aortic stenosis and severely reduced ejection fraction reported that average EF continued to climb over time, reaching about 41% at final follow-up, representing a doubling from the pre-procedure baseline in some patients.³

The multicenter TOPAS study reinforced this pattern: patients with low-flow, low-gradient aortic stenosis who underwent valve replacement showed significant improvements in ejection fraction, exercise capacity, and daily functioning during follow-up, while those who did not have surgery saw no improvement or got worse.⁴

Aortic Regurgitation Is a Different Story

When the aortic valve leaks rather than narrows, the left ventricle deals with volume overload instead of pressure overload. Blood flows backward into the chamber after each beat, forcing it to handle a larger-than-normal volume. The chamber stretches and enlarges over time, and the muscle eventually weakens. Replacing or repairing the valve stops the leak, and in most cases the ventricle shrinks back toward a normal size and pumps better.

A study of 246 patients who had surgery for chronic aortic regurgitation found that left ventricular function and symptoms improved significantly at one year. However, about 14% of patients did not recover normal function and structure.⁵ The patients who failed to recover tended to have lower preoperative ejection fractions and larger ventricles before surgery, suggesting that waiting too long before operating can cost you the chance at full recovery.

A study focused specifically on patients with severely reduced ejection fraction found that mean EF climbed from 26% to 35% in the first year and continued rising to about 46% with longer follow-up. Patients with pure aortic regurgitation, pure aortic stenosis, and mixed disease all saw significant improvement, and five-year survival matched that of the general population.⁶

Why Ejection Fraction Often Drops After Mitral Valve Surgery

Mitral valve disease presents one of the most counterintuitive patterns in cardiac surgery. When the mitral valve leaks badly, blood escapes backward into the left atrium during each contraction. That backward escape route actually makes it easier for the ventricle to empty, which can inflate the ejection fraction number and mask underlying muscle damage. Once the valve is repaired or replaced and that leak is sealed, the ventricle suddenly has to pump all its blood forward against normal resistance. The ejection fraction measured after surgery reflects the true pumping strength of the muscle, which was always lower than the preoperative number suggested.

A study tracking ejection fraction after mitral valve repair found that the higher a patient’s preoperative EF was, the larger the immediate drop afterward. Patients who started with an EF above 70% experienced the biggest initial decline. In the mid-range groups (preoperative EF between 50% and 70%), ejection fraction gradually climbed back over three to four years and eventually leveled off at around 60%.⁷ Interestingly, the group that started above 70% saw their EF drop, then partially recover, then gradually decline again over the long term to a level below that of patients who started in the 50-60% range. This likely reflects the fact that an unusually high preoperative EF in the setting of severe mitral regurgitation is a sign that the ventricle was overloaded and relying on that backward leak to look good on paper.

An older but influential study of patients who had mitral valve replacement for isolated mitral regurgitation found that 62% of long-term survivors had an ejection fraction drop of 10 or more percentage points after surgery. Yet 98% of those survivors were in good functional condition, with minimal or no symptoms.⁸ This disconnect between the EF number and how the patient actually feels is one of the most important points for anyone tracking their recovery after mitral surgery.

A cardiac MRI study comparing mitral valve repair with mitral valve replacement found that both approaches produced comparable improvements in left ventricular volumes, left atrial size, and exercise capacity at six months, even when ejection fraction itself did not rise dramatically.⁹ The heart was remodeling in beneficial ways, shrinking back toward a normal size, even if the EF number did not fully capture that improvement.

Tricuspid Valve and Right Ventricular Recovery

Most discussions about ejection fraction after valve surgery focus on the left ventricle, but the right side of the heart has its own recovery story. The right ventricle pushes blood through the lungs, and when the tricuspid valve leaks severely, the right ventricle can enlarge and weaken just as the left ventricle does with mitral disease.

A study of patients who had isolated tricuspid valve surgery found that right ventricular volumes dropped significantly and right ventricular ejection fraction improved from about 30% to 38% at a mean follow-up of roughly four months.¹⁰ Early reverse remodeling of the right ventricle after tricuspid surgery has also been linked to better long-term survival, and outcomes are best when surgery happens before right ventricular systolic dysfunction becomes entrenched.¹¹

For patients undergoing transcatheter tricuspid repair rather than open surgery, a recent study found that about 48% of those with baseline right ventricular dysfunction recovered during follow-up. Recovery was most common in patients who started with only mild dysfunction and whose leak was reduced to a mild level by the procedure.¹²

How Quickly Recovery Happens

The speed of ejection fraction recovery varies by procedure type and starting condition. For transcatheter aortic valve replacement, recovery can be strikingly fast. One study found that early EF recovery occurred in 62% of patients, often before they even left the hospital. By 30 days, the early-recovery group had gained more than 17 percentage points compared to baseline.¹³

That said, transcatheter and surgical approaches appear to converge over time. A study comparing TAVI and surgical valve replacement in patients with reduced EF found that TAVI was associated with faster EF recovery in the first week, but by three months the two groups looked the same on echocardiography.¹⁴ Open-heart surgery creates temporary inflammation and stunning of the heart muscle that delays recovery in the first days to weeks, but the heart catches up once it heals from the surgical trauma.

For mitral valve disease, as noted above, the trajectory is longer. Patients with preoperative EFs in the moderate range may take three to four years to reach their plateau. The first echocardiogram after mitral surgery often looks worse than the preoperative one, and patients who are not warned about this can become unnecessarily alarmed.

What Predicts Whether Your EF Will Recover

Not everyone gets the same degree of recovery, and researchers have spent decades trying to identify who will bounce back and who will not. Several factors consistently emerge.

Preoperative ejection fraction itself is a predictor, but not in the way you might expect. For aortic valve disease, patients with the lowest starting EFs sometimes show the most dramatic absolute gains, simply because they have the most room to improve. For mitral regurgitation, a high preoperative EF can be misleading, since it may be artificially inflated by the backward leak.

Myocardial fibrosis, meaning scar tissue in the heart muscle, is one of the strongest predictors of poor recovery. When the heart remodels under chronic stress, some muscle cells die and are replaced by stiff scar tissue that cannot contract. A study of patients undergoing transcatheter aortic valve replacement found that a higher fibrosis score was associated with a significantly lower chance of reverse remodeling, with the odds of remodeling dropping by about two-thirds for patients with more fibrosis.¹⁵ A study in aortic regurgitation patients using cardiac MRI found that the amount of scar tissue at baseline was associated with less shrinkage of the ventricle after surgery.¹⁶ Once scar has replaced working muscle, valve surgery cannot bring those cells back.

A more advanced echocardiographic measurement called global longitudinal strain has emerged as a powerful predictor of recovery. Standard EF measures how much the chamber volume changes during a heartbeat, but strain measures how much the muscle itself deforms. In patients with mitral regurgitation, impaired strain before surgery predicted left ventricular dysfunction afterward, even when preoperative EF looked normal.¹⁷ A more recent study identified a specific strain threshold: patients with a global longitudinal strain worse than about -16% were much more likely to fail to recover after mitral valve replacement, with each percentage-point worsening in strain increasing the odds of poor remodeling.¹⁸ Current guidelines acknowledge that ejection fraction alone does not reliably predict who will recover after valve surgery, and strain is increasingly used alongside it in clinical decision-making.¹⁹

Why EF Recovery Matters for Long-Term Survival

Ejection fraction improvement after valve replacement is not just a number on a report. It correlates with how long patients live. An analysis of more than 3,100 patients who underwent aortic valve replacement for aortic stenosis found that left ventricular recovery was associated with better survival and fewer heart failure hospitalizations.²⁰

A study specifically examining five-year outcomes after transcatheter aortic valve replacement found that patients who gained at least some EF early on had lower rates of death at five years compared to those who did not. The benefit became especially steep once the gain exceeded about 10 percentage points, with an adjusted reduction in cardiac death risk of about 10% for every 5-point increase in EF.²¹ This makes a practical case for close echocardiographic follow-up in the months after valve replacement: if EF is not recovering as expected, clinicians can adjust medications, investigate other causes of dysfunction, or plan further interventions sooner.

When Other Heart Problems Complicate the Picture

Many patients who need valve surgery do not have isolated valve disease. They may also have coronary artery disease, high blood pressure, or problems with more than one valve. These comorbidities can dampen EF recovery even after a technically successful valve replacement.

A study of patients with severe aortic stenosis who underwent valve replacement found that while tissue Doppler measurements of left ventricular function improved in those who had isolated valve replacement, patients who had combined aortic valve replacement and coronary bypass surgery saw more limited improvement in certain functional measures.²² Still, combined surgery is considered feasible and worthwhile even in patients with reduced EF. A study of patients undergoing aortic valve replacement for severe aortic regurgitation and reduced ejection fraction concluded that surgery remained a reasonable option even when concomitant mitral regurgitation or coronary disease required additional procedures.²³

The presence of coronary artery disease is independently associated with less EF recovery after aortic valve replacement. One study found that the absence of coronary disease was an independent predictor of greater improvement in ejection fraction, while patients with significant coronary disease gained less.²⁴ This makes sense because coronary disease involves its own set of muscle damage, and fixing the valve does nothing to fix narrowed coronary arteries unless bypass grafting is performed simultaneously.

Sex Differences in Recovery

Men and women may recover differently after valve replacement, and the research on this is still evolving. An older study of aortic valve replacement patients with preoperative ventricular dysfunction found that women gained more EF than men, with female sex emerging as an independent predictor of greater improvement.²⁴ About 72% of patients improved, and the mean gain was roughly 17.5 percentage points.

However, more recent data suggests the picture may be more nuanced over time. A study of patients with low-flow aortic stenosis who underwent transcatheter valve replacement found that men showed a steady, continuous increase in EF over the first year. Women, by contrast, showed an initial improvement up to three months, then a plateau, followed by a decline approaching the 12-month mark.²⁵ Why this divergence occurs is not fully understood. Differences in how the heart muscle remodels under chronic pressure, hormonal influences on fibrosis, and the types of aortic stenosis that predominate in each sex (calcific in men versus more often fibrotic in women) are all being investigated.

When Ejection Fraction Stays Low but the Patient Improves

One of the most important things to understand is that ejection fraction is a single number trying to summarize a complex organ. It can miss forms of improvement that matter to the patient. After valve surgery, the heart may shrink back toward a normal size, the pressures inside the chambers may drop, the valves may stop leaking, and the patient may go from being winded walking across a room to resuming normal activities. All of this can happen while the ejection fraction number barely moves, or even declines.

As the mitral regurgitation data illustrates, nearly all long-term survivors of mitral valve replacement for isolated mitral regurgitation reported excellent functional status despite the majority having lower EF numbers than before surgery.⁸ The tissue Doppler study in aortic stenosis patients showed improvements in diastolic and systolic function that were picked up by advanced imaging even when standard EF measurements did not change.²²

This is why clinicians are increasingly turning to measures beyond ejection fraction to track recovery. Strain imaging, chamber volumes, filling pressures, and functional capacity assessments like the six-minute walk test all provide pieces of the puzzle that EF alone cannot capture. If your cardiologist tells you your EF has not improved much after valve surgery but your symptoms are clearly better and your heart is smaller on imaging, that is still a win. The number is a useful shorthand, but it was never designed to be the whole story.